Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 34Neoplasm Metastasis 5Breast Neoplasms 4Prostate Carcinoma Metastatic to the Bone 2Multiple Myeloma 2Metastatic Castration-resistant Prostate Cancer 2Hormone Refractory Prostate Cancer 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Prostate Cancer Metastatic to Bone 1Prostate Adenocarcinoma 1Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1Lymphatic Metastasis 1Lung Neoplasms 1Castrate-Resistant Prostate Cancer 1Bone Metastatic Castration-resistant Prostate Cancer 1Bone Metastases 1Bone Diseases 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Zoledronic Acid 4Denosumab 3Vitamin D 2saracatinib 1radium Ra 223 dichloride 1odanacatib 1etelcalcetide hydrochloride 1cabozantinib 1Standard of Care 1Progestins 1Pamidronate 1Paclitaxel 1Hormone Replacement Therapy 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1BHQ880 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bone Diseases × radium Ra 223 dichloride × Clear all
NCT02442063 2016-11-30

Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions

Bayer

Phase 1 Completed
15 enrolled

Bone Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡